NRIX vs. XBI
Compare and contrast key facts about Nurix Therapeutics, Inc. (NRIX) and SPDR S&P Biotech ETF (XBI).
XBI is a passively managed fund by State Street that tracks the performance of the S&P Biotechnology Select Industry Index. It was launched on Feb 6, 2006.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: NRIX or XBI.
Correlation
The correlation between NRIX and XBI is 0.61, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
NRIX vs. XBI - Performance Comparison
Key characteristics
NRIX:
0.92
XBI:
-0.02
NRIX:
1.83
XBI:
0.13
NRIX:
1.21
XBI:
1.02
NRIX:
0.84
XBI:
-0.01
NRIX:
3.73
XBI:
-0.06
NRIX:
18.00%
XBI:
9.43%
NRIX:
73.17%
XBI:
24.41%
NRIX:
-91.53%
XBI:
-63.89%
NRIX:
-66.37%
XBI:
-47.20%
Returns By Period
In the year-to-date period, NRIX achieves a -10.46% return, which is significantly lower than XBI's 1.82% return.
NRIX
-10.46%
-14.28%
-29.77%
59.91%
N/A
N/A
XBI
1.82%
0.54%
-9.65%
-2.46%
-1.09%
2.87%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
NRIX vs. XBI — Risk-Adjusted Performance Rank
NRIX
XBI
NRIX vs. XBI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Nurix Therapeutics, Inc. (NRIX) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
NRIX vs. XBI - Dividend Comparison
NRIX has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.15%.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRIX Nurix Therapeutics, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
XBI SPDR S&P Biotech ETF | 0.15% | 0.15% | 0.02% | 0.00% | 0.04% | 0.20% | 0.00% | 0.28% | 0.24% | 0.26% | 0.61% | 1.07% |
Drawdowns
NRIX vs. XBI - Drawdown Comparison
The maximum NRIX drawdown since its inception was -91.53%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for NRIX and XBI. For additional features, visit the drawdowns tool.
Volatility
NRIX vs. XBI - Volatility Comparison
Nurix Therapeutics, Inc. (NRIX) has a higher volatility of 11.39% compared to SPDR S&P Biotech ETF (XBI) at 5.71%. This indicates that NRIX's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.